Mucosal administration of hsp65 decreases atherosclerosis and inflammation in Aortic Arch of low-density lipoprotein receptor-deficient mice. - Maron,R.; Sukhova,G.; Faria,AM.; Hoffmann,E.; Mach,F.; Libby,P.; Weiner,HL. (Circulation, 2002)